Cited by 72Prion Diseases and Protein MisfoldingAlzheimer's disease research and treatmentsHeat shock proteins research

Cross Currents in Protein Misfolding Disorders: Interactions and Therapy

Open access
Morales, Rodrigo, Green, Kristi, Soto, Claudio·2009·CNS & Neurological Disorders - Drug Targets

Abstract

Protein Misfolding Disorders (PMDs) are a group of diseases characterized by the accumulation of abnormally folded proteins. Despite the wide range of proteins and tissues involved, PMDs share similar molecular and pathogenic mechanisms. Several epidemiological, clinical and experimental reports have described the co-existence of PMDs, suggesting a possible cross-talk between them. A better knowledge of the molecular basis of PMDs could have important implications for understanding the mechanism by which these diseases appear and progress and ultimately to develop novel strategies for treatment. Due to their similar molecular mechanisms, common therapeutic strategies could be applied for the diseases in this group.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/187152709789541998

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TDP-43 binds to many cellular transcripts including tau and alpha synuclein, and its dysregulation may underlie some of the pathologies seen with these proteins; TDP-43 may influence tau isoform expression.

    “TDP-43 binds to many cellular transcripts including tau and alpha synuclein, and its dysregulation may underlie some of the pathologies seen with these proteins [162]. In particular, TDP-43 may influence tau iso-form expression [136].”

    From The neuropathology of sport (2014) · cites this paper as [136]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 82 · Cited by 72

Research works printed but not linked: 3

  1. [49]Ott A Stolk RP van Harskamp F Pols HA Hofman A Breteler MM Diabetes mellitus and the risk of dementia; The Rotterdam Study Neurology 1999 53 1937 1942 10599761
  2. [53]Kokmen E Beard CM Chandra V Offord KP Schoenberg BS Ballard DJ Clinical risk factors for Alzheimer’s disease; a population-based case-control study Neurology 1991 41 1393 1397 1891088
  3. [81]Estrada LD Soto C Peptide inhibitors of protein misfolding and aggregation Curr Pharm Des 2006 12 2557 2568 16842178

Authors
Morales, R., Green, K., & Soto, C.
Affiliations
The University of Texas Health Science Center at Houston (US)
Venue
CNS & Neurological Disorders - Drug Targets
Published
2009-11-01
Volume
8
Issue
5
Pages
363-371
ISSN
  • 1568-007X (ISSN-L)
  • 1871-5273
OpenAlex
W2141412231
Cited by
72
References
82
Citations by year
2026: 2 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 8 · 2019: 3 · 2018: 5 · 2017: 2 · 2016: 7 · 2015: 7 · 2014: 6 · 2013: 9 · 2012: 6
FWCI
1.21
Type
journal article
Language
en
Open access
Locations
  • CNS & Neurological Disorders - Drug Targets (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Commons-TMC (Texas Medical Center) (submittedVersion)
Funders
  • National Institute on Aging (R01AG028821)
  • National Institute of Neurological Disorders and Stroke (R01NS050349)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Keywords
proteinopathies, protein aggregation, protein folding, pathophysiological mechanisms, treatment options, neurodegenerative diseases
MeSH terms
Protein Conformation, Prion Diseases, Protein Folding, Proteostasis Deficiencies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review